Get the Stockscreener App
137.76
1.27%
1.73
After Hours:
137.76
Davita Inc stock is traded at $137.76, with a volume of 531.32K.
It is up +1.27% in the last 24 hours and down -5.63% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$136.03
Open:
$136.08
24h Volume:
531.32K
Relative Volume:
0.66
Market Cap:
$9.85B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
12.83
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-1.85%
1M Performance:
-5.63%
6M Performance:
-6.84%
1Y Performance:
-10.10%
1-Day Range:
$135.74
$137.77
1-Week Range:
$134.71
$141.00
52-Week Range:
$126.07
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
137.76 | 9.84B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
403.96 | 94.78B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
184.33 | 16.08B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.70 | 14.75B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
121.76 | 12.45B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
181.58 | 11.61B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Best data tools to analyze DaVita Inc. stockMarket Growth Review & High Accuracy Buy Signal Tips - Newser
Price action breakdown for DaVita Inc.July 2025 Technicals & Verified Momentum Stock Alerts - Newser
Using RSI to spot recovery in DaVita Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
When is the best time to exit DaVita Inc.2025 Performance Recap & Entry Point Strategy Guides - Newser
Stock Analysis | DaVita OutlookMixed Signals Emerge Amid Volatile Market Conditions - AInvest
Will earnings trigger a reversal in DaVita Inc.Market Performance Summary & Precise Swing Trade Alerts - Newser
Real time pattern detection on DaVita Inc. stock2025 Stock Rankings & Expert Curated Trade Ideas - Newser
DaVita (DVA) Confirms Ransomware Attack Impacted 2.7M People - MSN
DaVita Inc. Confirms Ransomware Attack Impacted 2.7M People - AInvest
Does DaVita Inc. qualify in momentum factor screeningEarnings Overview Report & Technical Pattern Based Signals - Newser
Will DaVita Inc. stock go up soon2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - Newser
Chart based exit strategy for DaVita Inc.2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Can you recover from losses in DaVita Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - Newser
13 Best Long-Term Stocks to Invest in According to Warren Buffett - Insider Monkey
Analysts Forecast 10% Gain Ahead for PBP ETF; DaVita, Smucker, and NextEra Energy Holdings Show Upside - AInvest
Published on: 2025-08-28 23:38:38 - Newser
Understanding DaVita Inc.’s price movementMarket Growth Review & Detailed Earnings Play Strategies - Newser
Using data models to predict DaVita Inc. stock movementJuly 2025 Action & AI Enhanced Trading Signals - Newser
What makes DaVita Inc. stock price move sharplyTreasury Yields & Daily Chart Pattern Signal Reports - Newser
How to build a custom watchlist for DaVita Inc.2025 Trading Recap & Reliable Breakout Forecasts - Newser
Is it time to cut losses on DaVita Inc.Market Movers & Safe Entry Trade Reports - Newser
DaVita Inc. (DVA): A Bull Case Theory - Insider Monkey
500+ Clinical Trials: How DaVita's Research Division Transformed Kidney Care Over 25 Years - Stock Titan
Will DaVita Inc. continue its uptrendCPI Data & Fast Gaining Stock Strategy Reports - Newser
Custom watchlist performance reports with DaVita Inc.2025 EndofYear Setup & Technical Pattern Based Signals - Newser
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):